Tenet Healthcare (NYSE: THC) director Roy Blunt sells 600 shares

Rhea-AI Filing Summary

Tenet Healthcare Corp director Roy Blunt reported selling 600 shares of Common Stock on 2026-08-05 at a weighted average price of $262.68 per share, executed in multiple trades between $262.52 and $262.70. After this sale, he directly holds 4,589 shares.

Insider Trade Summary

Net Seller: 600 shares

Net Sell 1 txn

Insider Blunt Roy

Role Director

Sold 600 shs ($158K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	600	$262.68	$158K

Holdings After Transaction: Common Stock — 4,589 shares (Direct)

Footnotes (1)

1. F1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $262.52 to $262.70. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

Key Figures

Shares sold: 600 shares Weighted average sale price: $262.68 per share Sale price range: $262.52–$262.70 per share +1 more

4 metrics

Shares sold 600 shares Common Stock sold on 2026-08-05 by director Roy Blunt

Weighted average sale price $262.68 per share Average price for Common Stock sale on 2026-08-05

Sale price range $262.52–$262.70 per share Price range across multiple sale transactions on 2026-08-05

Shares owned after transaction 4,589 shares Direct Common Stock holdings following 2026-08-05 sale

Key Terms

weighted average sales price, aggregate number of shares, multiple transactions

3 terms

weighted average sales price financial

"The price is the weighted average sales price of the aggregate number"

aggregate number of shares financial

"of the aggregate number of shares that were sold by the reporting"

multiple transactions financial

"These shares were sold in multiple transactions at prices ranging"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/07/2026 - 08:00 PM Accepted by SEC EDGAR 08/07/2026 - 08:00 PM Learn about SEC filing dates

FAQ

What did Tenet Healthcare (THC) director Roy Blunt report in this Form 4?

He reported an open-market sale of 600 Tenet Healthcare common shares. The transaction occurred on 2026-08-05 at a weighted average price of $262.68 per share, with trade prices ranging from $262.52 to $262.70, leaving him with 4,589 shares.

How many Tenet Healthcare (THC) shares did Roy Blunt sell and at what price?

Roy Blunt sold 600 shares of Tenet Healthcare Common Stock. The weighted average sale price was $262.68 per share, with individual trades executed in a price range between $262.52 and $262.70 on 2026-08-05.

How many Tenet Healthcare (THC) shares does Roy Blunt own after the reported sale?

Following the reported sale, Roy Blunt directly owns 4,589 shares of Tenet Healthcare Common Stock. This figure reflects his direct holdings immediately after selling 600 shares on 2026-08-05 at a weighted average price of $262.68 per share.

Over what price range were Roy Blunt’s Tenet Healthcare (THC) shares sold?

The 600 Tenet Healthcare shares were sold at prices ranging from $262.52 to $262.70 per share. The reported transaction price of $262.68 represents a weighted average sales price across these multiple trades executed on 2026-08-05.

Was Roy Blunt’s Tenet Healthcare (THC) stock sale reported as a weighted average price?

Yes. The sale was reported using a weighted average sales price of $262.68 per share. A footnote explains the shares were sold in multiple transactions between $262.52 and $262.70, and detailed trade prices are available upon request.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blunt Roy

(Last) (First) (Middle)

14201 DALLAS PARKWAY

(Street)

DALLAS TEXAS 75254

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TENET HEALTHCARE CORP [ THC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/05/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/05/2026		S		600	D	$262.68(1)	4,589	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price is the weighted average sales price of the aggregate number of shares that were sold by the reporting person. These shares were sold in multiple transactions at prices ranging from $262.52 to $262.70. The reporting person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.

	Chad J. Wiener, as Attorney-in-fact for Roy Blunt	08/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)